Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas E Kline

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Oncoimmunology|November 2, 2013
Peripheral T-cell tolerance in hosts with acute myeloid leukemiaXiufen Chen, Douglas E Kline, Justin Kline
Oncoimmunology|May 17, 2017
Calreticulin promotes immunity and type I interferon-dependent survival in mice with acute myeloid leukemiaXiufen Chen, Dominick Fosco, Douglas E Kline, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 14, 2018
CD8α<sup>+</sup> Dendritic Cells Dictate Leukemia-Specific CD8<sup>+</sup> T Cell FatesDouglas E Kline, Brendan W MacNabb, Xiufen Chen, et al.
European Journal of Immunology|July 1, 2014
PD-1 regulates extrathymic regulatory T-cell differentiationXiufen Chen, Dominick Fosco, Douglas E Kline, et al.
The Journal of Clinical Investigation|April 27, 2013
CD40 ligation reverses T cell tolerance in acute myeloid leukemiaLong Zhang, Xiufen Chen, Xiao Liu, et al.
Cell Reports|June 7, 2016
STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid LeukemiaEmily Curran, Xiufen Chen, Leticia Corrales, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2019
Negligible Role for Deletion Mediated by cDC1 in CD8<sup>+</sup> T Cell ToleranceBrendan W MacNabb, Douglas E Kline, Annie R Albright, et al.
Diabetes|July 4, 2012
Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodiesZuoan Yi, Ramiro Diz, Aaron J Martin, et al.
JCI Insight|October 26, 2016
Anti-coreceptor therapy drives selective T cell egress by suppressing inflammation-dependent chemotactic cuesAaron J Martin, Matthew Clark, Gregory Gojanovich, et al.
Toxicology and Applied Pharmacology|January 30, 2013
All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxinQiang Zhang, Douglas E Kline, Sudin Bhattacharya, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Oncoimmunology|November 2, 2013
Peripheral T-cell tolerance in hosts with acute myeloid leukemiaXiufen Chen, Douglas E Kline, Justin Kline
Oncoimmunology|May 17, 2017
Calreticulin promotes immunity and type I interferon-dependent survival in mice with acute myeloid leukemiaXiufen Chen, Dominick Fosco, Douglas E Kline, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 14, 2018
CD8α<sup>+</sup> Dendritic Cells Dictate Leukemia-Specific CD8<sup>+</sup> T Cell FatesDouglas E Kline, Brendan W MacNabb, Xiufen Chen, et al.
European Journal of Immunology|July 1, 2014
PD-1 regulates extrathymic regulatory T-cell differentiationXiufen Chen, Dominick Fosco, Douglas E Kline, et al.
The Journal of Clinical Investigation|April 27, 2013
CD40 ligation reverses T cell tolerance in acute myeloid leukemiaLong Zhang, Xiufen Chen, Xiao Liu, et al.
Cell Reports|June 7, 2016
STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid LeukemiaEmily Curran, Xiufen Chen, Leticia Corrales, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2019
Negligible Role for Deletion Mediated by cDC1 in CD8<sup>+</sup> T Cell ToleranceBrendan W MacNabb, Douglas E Kline, Annie R Albright, et al.
Diabetes|July 4, 2012
Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodiesZuoan Yi, Ramiro Diz, Aaron J Martin, et al.
JCI Insight|October 26, 2016
Anti-coreceptor therapy drives selective T cell egress by suppressing inflammation-dependent chemotactic cuesAaron J Martin, Matthew Clark, Gregory Gojanovich, et al.
Toxicology and Applied Pharmacology|January 30, 2013
All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxinQiang Zhang, Douglas E Kline, Sudin Bhattacharya, et al.
Pageof 2